Japanese Encephalitis

Содержание

Слайд 2

Japanese encephalitis is a mosquito-borne viral infection of horses, pigs and

Japanese encephalitis is a mosquito-borne viral infection of horses, pigs and

humans.
It is also referred to as Japanese B encephalitis, arbovirus B, and mosquito-borne encephalitis virus.
Слайд 3

Geographic Distribution of Japanese Encephalitis Virus

Geographic Distribution of Japanese Encephalitis Virus

Слайд 4

The Organism Japanese Encephalitis (JE) virus belongs to the genus Flavivirus

The Organism

Japanese Encephalitis (JE) virus belongs to the genus Flavivirus in

the family Flaviviridae
Name derived from the Latin flavus meaning “yellow”, which refers to the yellow fever virus
Single stranded, enveloped RNA virus
Morphology not well defined
Слайд 5

History 1870s: Japan “Summer encephalitis” epidemics 1924: Great epidemic in Japan

History

1870s: Japan
“Summer encephalitis” epidemics
1924: Great epidemic in Japan
6,125 human cases; 3,797

deaths
1935: Virus first isolated
Fatal human encephalitis case
1938: Virus isolated from mosquito Culex tritaeniorhynchus
Слайд 6

History 1940 to 1978 Disease spread with epidemics in China, Korea,

History

1940 to 1978
Disease spread with epidemics in China, Korea, and India
1983:

Immunization in South Korea
Started as early as age 3
Endemic areas started earlier
1983 to 1987: Vaccine available in U.S. on investigational basis
Слайд 7

Transmission Vector-borne Enzootic cycle Mosquitoes: Culex species Culex tritaeniorhynchus Reservoir/amplifying hosts

Transmission

Vector-borne
Enzootic cycle
Mosquitoes: Culex species
Culex tritaeniorhynchus
Reservoir/amplifying hosts
Pigs, bats, Ardeid (wading) birds
Possibly reptiles

and amphibians
Incidental hosts
Horses, humans, others
Слайд 8

Слайд 9

Transmission is usually seasonal In temperate zones of China, Japan, Korea

Transmission is usually seasonal
In temperate zones of China, Japan, Korea

and northern areas of Southeast Asia, Japanese encephalitis is transmitted during summer and early autumn -- May to September.
In north India and Nepal transmission occurs from June to November
In south India and Sri Lanka epidemics are found from September to January.

Transmission

Слайд 10

Clinical Signs Every year approximately 35,000 to 50,000 symptomatic cases occur

Clinical Signs

Every year approximately 35,000 to 50,000 symptomatic cases occur worldwide


Incubation period: 6 to 8 days
Disease varies from a febrile headache to an acute and possibly fatal encephalitis
Most asymptomatic or mild signs
Children and elderly
Highest risk for severe disease
case-fatality rate (30%)
Слайд 11

Clinical Signs: Severe Acute encephalitis Headache, high fever, stiff neck, stupor

Clinical Signs: Severe

Acute encephalitis
Headache, high fever, stiff neck, stupor
May progress

to paralysis, seizures, convulsions, coma, and death
Neuropsychiatric complication
45 to 70% of survivors
In utero infection possible
Abortion of fetus

Center for Food Security and Public Health, Iowa State University, 2011

Слайд 12

Слайд 13

Слайд 14

Слайд 15

Слайд 16

Post Mortem Lesions Pan-encephalitis Infected neurons throughout CNS Occasional microscopic necrotic

Post Mortem Lesions

Pan-encephalitis
Infected neurons throughout CNS
Occasional microscopic necrotic foci
Thalamus generally severely

affected

The perivascular congestion and hemorrhage may be diffuse or focal, and is seen predominantly in cortical gray and deep gray matter.

Слайд 17

Age groups affected by JE Children 1 to 15 years of

Age groups affected by JE

Children 1 to 15 years of age

are mainly affected in endemic areas.
But people of any age can be infected. Adult infection most often occurs in areas where the disease is newly introduced.

Photo credit: Carib Nelson, PATH

Слайд 18

Data supplied by Government of Andhra Pradesh Data supplied by WHO,

Data supplied by Government of Andhra Pradesh

Data supplied by WHO, Nepal

Different

patterns of age distribution of cases
Слайд 19

Diagnosis and Treatment Laboratory diagnosis required Tentative diagnosis Antibody titer: HI,

Diagnosis and Treatment

Laboratory diagnosis required
Tentative diagnosis
Antibody titer: HI, IFA, ELISA
JE-specific IgM

in serum or CSF
Definitive diagnosis
Virus isolation: CSF, brain
No specific treatment
Supportive care

Center for Food Security and Public Health, Iowa State University, 2011

Слайд 20

Vaccination Live attenuated vaccine horses and swine Successful for reducing incidence

Vaccination

Live attenuated vaccine
horses and swine
Successful for reducing incidence
Inactivated vaccine (JE-VAX)
Humans
Japan, Korea,

Taiwan, India, Thailand
Used for endemic or epidemic areas
Travelers, military, laboratory workers